Web-based Genetic Research on Lupus

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Study of Lupus Patients and Their Families

NCT00235378

Systemic Lupus Erythematosus

COMPLETED

Lupus Genetics Studies

NCT00071175

Systemic Lupus Erythematosus

COMPLETED

Genetic Analysis of Psoriasis and Psoriatic Arthritis

NCT00341809

Psoriasis

COMPLETED

A Study of Genetic Variation Influencing Pain and Response to Opioid Medications

NCT01293994

Pain

WITHDRAWN

Deciphering the Genetic Architecture of Autoimmune Diseases

NCT06948110

Autoimmune Diseases

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Lupus Erythematosus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lupus patients

People diagnosed with Systemic Lupus Erythematosus by a physician

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed with lupus by a qualified physician.
* consents to have 23andMe (via a partner) contact the physician to obtain medical record information
* willing to submit a saliva sample for DNA testing and complete online surveys related to condition
* at least 6 years old (minors under 18 require parental consent to enroll)
* access to the internet
* resides in the United States